Evaluation of Artificial Intelligence-Integrated Hearing Aids for Individuals with Hearing Loss
NCT ID: NCT06792110
Last Updated: 2025-01-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
100 participants
INTERVENTIONAL
2025-02-01
2026-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. How effective is an artificial intelligence integrated hearing aid in improving speech perception in noise.
2. How does an artificial intelligence integrated hearing aid compare to currently available commercial hearing aids.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Comparison of Hearing Aid Noise Programs on Speech Intelligibility
NCT06957730
AI Noise Reduction in Phonak Hearing Aids
NCT06743295
Evaluating a Deep Neural Noise-Reduction Algorithm for Hearing Aids
NCT07287774
Preference Comparisons for Algorithms to Hear Speech
NCT05561335
Evaluation of Hearing Aid Benefit
NCT05198713
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators have developed a neural network that runs on-device to achieve real-time target speech hearing in realistic multi-talker environments. Using our neural network, the wearer can focus on speech from a target speaker by learning their unique speech cues while ignoring all interfering speech and noise in complex acoustic environments. The wearer is additionally able to use distance to separate sounds from the environment from target sounds to be amplified. Finally the wearer is also able to specificy categories of sound that will be amplified in environment.
This study will prospectively study a hearing aid implementing these algorithms on individuals with hearing loss. Participants will be randomized to utilizing one of two commercial hearing aids vs the experimental device. Participants will participate in listening tests in which they must identify the words spoken by a specific voice in multi-talker babble noise. The investigators will measure performance with the primary and secondary outcome measures listed elsewhere.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oticon Hearing Aid vs Experimental Hearing Aid
Participants will use both one hearing aid model that is commercial and the experimental hearing aid on listening tasks.
Artificial Intelligence Integrated Hearing Aid Use
Participants in this arm will use the study-designed artificial intelligence-integrated hearing aid in the listening tasks. Participants will also perform the listening tasks without hearing aids to act as controls.
Phonak Infineo Hearing Aid
Participants in this arm will use a fitted commercial hearing aid in the listening tasks. Participants will also perform the listening tasks without hearing aids to act as controls.
Phonak Hearing Aid vs Experimental Hearing Aids
Participants will use both one hearing aid model that is commercial and the experimental hearing aid on listening tasks.
Artificial Intelligence Integrated Hearing Aid Use
Participants in this arm will use the study-designed artificial intelligence-integrated hearing aid in the listening tasks. Participants will also perform the listening tasks without hearing aids to act as controls.
Oticon Real Hearing Aid
Participants in this arm will use a fitted commercial hearing aid in the listening tasks. Participants will also perform the listening tasks without hearing aids to act as controls.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Artificial Intelligence Integrated Hearing Aid Use
Participants in this arm will use the study-designed artificial intelligence-integrated hearing aid in the listening tasks. Participants will also perform the listening tasks without hearing aids to act as controls.
Phonak Infineo Hearing Aid
Participants in this arm will use a fitted commercial hearing aid in the listening tasks. Participants will also perform the listening tasks without hearing aids to act as controls.
Oticon Real Hearing Aid
Participants in this arm will use a fitted commercial hearing aid in the listening tasks. Participants will also perform the listening tasks without hearing aids to act as controls.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Bilateral sensorineural hearing loss amenable to hearing aids
* Able to give informed consent
* Native English speaker
* Able to wear a standard pair of hearing aids
Exclusion Criteria
* Use of a cochlear implant
* Hearing loss not amenable to hearing aid use
* Conductive hearing loss
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Washington
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gavriel Kohlberg
Assistant Professor, School of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gavriel Kohlberg, MD
Role: PRINCIPAL_INVESTIGATOR
University of Washington
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00018443
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.